Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 122

1.

Declining morbidity and mortality among patients with advanced human immunodeficiency virus infection. HIV Outpatient Study Investigators.

Palella FJ Jr, Delaney KM, Moorman AC, Loveless MO, Fuhrer J, Satten GA, Aschman DJ, Holmberg SD.

N Engl J Med. 1998 Mar 26;338(13):853-60.

2.

Surveillance for AIDS-defining opportunistic illnesses, 1992-1997.

Jones JL, Hanson DL, Dworkin MS, Alderton DL, Fleming PL, Kaplan JE, Ward J.

MMWR CDC Surveill Summ. 1999 Apr 16;48(2):1-22.

PMID:
12412613
3.

Changes in AIDS-defining illnesses in a London Clinic, 1987-1998.

Mocroft A, Sabin CA, Youle M, Madge S, Tyrer M, Devereux H, Deayton J, Dykhoff A, Lipman MC, Phillips AN, Johnson MA.

J Acquir Immune Defic Syndr. 1999 Aug 15;21(5):401-7.

PMID:
10458621
4.
5.

Clinical spectrum, morbidity, and mortality of acquired immunodeficiency syndrome in Taiwan: a 5-year prospective study.

Hung CC, Chen MY, Hsieh SM, Sheng WH, Chang SC.

J Acquir Immune Defic Syndr. 2000 Aug 1;24(4):378-85.

PMID:
11015155
6.

Discontinuation of primary prophylaxis against Pneumocystis carinii pneumonia in HIV-1-infected adults treated with combination antiretroviral therapy. Swiss HIV Cohort Study.

Furrer H, Egger M, Opravil M, Bernasconi E, Hirschel B, Battegay M, Telenti A, Vernazza PL, Rickenbach M, Flepp M, Malinverni R.

N Engl J Med. 1999 Apr 29;340(17):1301-6.

7.

Long-term clinical benefit after highly active antiretroviral therapy in advanced HIV-1 infection, even in patients without immune reconstitution.

Arici C, Ripamonti D, Ravasio V, Maggiolo F, Rizzi M, Finazzi MG, Suter F.

Int J STD AIDS. 2001 Sep;12(9):573-81.

PMID:
11516366
8.

Pneumocystis carinii pneumonia incidence and chemoprophylaxis failure in ambulatory HIV-infected patients. HIV Outpatient Study (HOPS) Investigators.

Moorman AC, Von Bargen JC, Palella FJ, Holmberg SD.

J Acquir Immune Defic Syndr Hum Retrovirol. 1998 Oct 1;19(2):182-8.

PMID:
9768629
9.

Natural history of opportunistic disease in an HIV-infected urban clinical cohort.

Moore RD, Chaisson RE.

Ann Intern Med. 1996 Apr 1;124(7):633-42.

PMID:
8607591
10.

Discontinuation of secondary prophylaxis against Pneumocystis carinii pneumonia in patients with HIV infection who have a response to antiretroviral therapy. Eight European Study Groups.

Ledergerber B, Mocroft A, Reiss P, Furrer H, Kirk O, Bickel M, Uberti-Foppa C, Pradier C, D'Arminio Monforte A, Schneider MM, Lundgren JD; Eight European Study Groups.

N Engl J Med. 2001 Jan 18;344(3):168-74.

11.

Discontinuation of prophylaxis for Mycobacterium avium complex disease in HIV-infected patients who have a response to antiretroviral therapy. Terry Beirn Community Programs for Clinical Research on AIDS.

El-Sadr WM, Burman WJ, Grant LB, Matts JP, Hafner R, Crane L, Zeh D, Gallagher B, Mannheimer SB, Martinez A, Gordin F.

N Engl J Med. 2000 Apr 13;342(15):1085-92.

12.

A randomized trial of the discontinuation of primary and secondary prophylaxis against Pneumocystis carinii pneumonia after highly active antiretroviral therapy in patients with HIV infection. Grupo de Estudio del SIDA 04/98.

Lopez Bernaldo de Quiros JC, Miro JM, Peña JM, Podzamczer D, Alberdi JC, Martínez E, Cosin J, Claramonte X, Gonzalez J, Domingo P, Casado JL, Ribera E; Grupo de Estudio del SIDA 04/98.

N Engl J Med. 2001 Jan 18;344(3):159-67.

13.

Natural history of HIV infection in the era of combination antiretroviral therapy.

Moore RD, Chaisson RE.

AIDS. 1999 Oct 1;13(14):1933-42.

PMID:
10513653
14.

Effects of antiretroviral therapy and opportunistic illness primary chemoprophylaxis on survival after AIDS diagnosis. Adult/Adolescent Spectrum of Disease Group.

McNaghten AD, Hanson DL, Jones JL, Dworkin MS, Ward JW.

AIDS. 1999 Sep 10;13(13):1687-95. Erratum in: AIDS 2000 Aug 18;14(12):1877.

PMID:
10509570
15.

Improved survival among HIV-infected patients after initiation of triple-drug antiretroviral regimens.

Hogg RS, Yip B, Kully C, Craib KJ, O'Shaughnessy MV, Schechter MT, Montaner JS.

CMAJ. 1999 Mar 9;160(5):659-65.

16.

Incidence and spectrum of AIDS-defining illnesses among persons treated with antiretroviral drugs.

Michaels SH, Clark R, Kissinger P.

Clin Infect Dis. 1999 Aug;29(2):468-9. No abstract available.

17.

HIV infection/acquired immunodeficiency syndrome at Siriraj Hospital, 2002: time for secondary prevention.

Anekthananon T, Ratanasuwan W, Techasathit W, Rongrungruang Y, Suwanagool S.

J Med Assoc Thai. 2004 Feb;87(2):173-9.

PMID:
15061301
18.
20.

Effectiveness of potent antiretroviral therapies on the incidence of opportunistic infections before and after AIDS diagnosis.

Detels R, Tarwater P, Phair JP, Margolick J, Riddler SA, Muñoz A; Multicenter AIDS Cohort Study.

AIDS. 2001 Feb 16;15(3):347-55.

PMID:
11273215
Items per page

Supplemental Content

Write to the Help Desk